Routine Pathologic Examination of the Femoral Head in Total Hip Arthroplasty: A Survey Study of the American Association of Hip and Knee Surgeons
- PMID: 36691462
- PMCID: PMC9860103
- DOI: 10.1016/j.artd.2022.101079
Routine Pathologic Examination of the Femoral Head in Total Hip Arthroplasty: A Survey Study of the American Association of Hip and Knee Surgeons
Abstract
Background: Current literature does not provide conclusive evidence on whether routine pathologic examination of femoral heads from total hip arthroplasty is indicated or cost-effective. As a result, there is substantial variation in opinion among surgeons related to this issue. Our study aim was to determine factors that impact surgeon propensity to order pathologic examination of femoral heads.
Methods: A 12-question survey was created to evaluate surgeon practices, indications, and patient care implications surrounding routine pathologic examination of femoral heads. The email survey was distributed to all members of the American Association of Hip and Knee Surgeons (n = 2598).
Results: There were 572 survey respondents. Out of all respondents, 28.4% always send femoral heads to pathology, and 27.6% reported an institutional requirement to do so. Of the 572 surgeons, 73.6% report femoral head pathology has never resulted in a change in patient disease course. Factors that increase the likelihood of surgeons ordering femoral head pathologic examination include institutional requirements, medicolegal concern, and prior experience with femoral head pathologic examination changing patients' disease course (P < .001). Cost concern decreases the likelihood of surgeons ordering femoral head pathologic examination (P = .0012).
Conclusions: A minority of surgeons routinely send femoral heads from total hip arthroplasty for pathologic examination, mostly because of institutional requirement. The majority of surgeons feel that femoral head pathologic examination never changes patient management, although others have infrequently detected malignancy and infection. Institutional policy, concern for litigation, and prior experience with discordant pathologic diagnoses increase femoral head pathologic examinations, while cost concern decreases them.
Keywords: Arthroplasty; Cost; Femoral head; Hip; Pathology; Routine.
Figures





Similar articles
-
Routine Pathologic Examination of Femoral Head Specimens from Total Hip Arthroplasty May Not Be Indicated or Cost-effective: A Systematic Review.Arthroplast Today. 2022 May 9;15:182-187.e3. doi: 10.1016/j.artd.2022.03.016. eCollection 2022 Jun. Arthroplast Today. 2022. PMID: 35774889 Free PMC article.
-
Unsuspected Malignancies in Routine Femoral Head Histopathologic Examination During Primary Total Hip Arthroplasty: Cost-Effectiveness Analysis.J Arthroplasty. 2017 Mar;32(3):735-742. doi: 10.1016/j.arth.2016.08.017. Epub 2016 Aug 24. J Arthroplasty. 2017. PMID: 27697361
-
Selective pathological examination following hip arthroplasty: A retrospective cohort study.Orthop Traumatol Surg Res. 2022 Apr;108(2):102942. doi: 10.1016/j.otsr.2021.102942. Epub 2021 Apr 22. Orthop Traumatol Surg Res. 2022. PMID: 33895385
-
Is Oxidized Zirconium Femoral Head Superior to Other Bearing Types in Total Hip Arthroplasty? A Systematic Review and Meta-Analysis.J Arthroplasty. 2019 Aug;34(8):1844-1852. doi: 10.1016/j.arth.2019.03.072. Epub 2019 Apr 2. J Arthroplasty. 2019. PMID: 31010775
-
Risk Stratification Algorithm for Management of Head-Neck Taper Tribocorrosion in Patients with Metal-on-Polyethylene Total Hip Arthroplasty: Consensus Statement of the American Association of Hip and Knee Surgeons, the American Academy of Orthopaedic Surgeons, and The Hip Society.J Bone Joint Surg Am. 2021 Mar 3;103(5):e18. doi: 10.2106/JBJS.20.01837. J Bone Joint Surg Am. 2021. PMID: 33411461 Review.
Cited by
-
Routine Pathologic Examination of Femoral Heads is Not Warranted.Arthroplast Today. 2025 Jan 23;31:101624. doi: 10.1016/j.artd.2025.101624. eCollection 2025 Feb. Arthroplast Today. 2025. PMID: 39927122 Free PMC article. No abstract available.
References
-
- Singh J.A., Yu S., Chen L., Cleveland J.D. Rates of total joint replacement in the United States: future projections to 2020-2040 using the National inpatient sample. J Rheumatol. 2019;46:1134–1140. - PubMed
-
- Sloan M., Premkumar A., Sheth N.P. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am. 2018;100:1455–1460. - PubMed
-
- Loftus T., Agee C., Jaffe R., Tao J., Jacofsky D.J. A simplified pathway for total knee arthroplasty improves outcomes. J Knee Surg. 2014;27:221–228. - PubMed
-
- Schubert A., Patterson M., Sumrall W.D., Broussard D., Dias D., Aboalfaraj A., et al. Perioperative population management for primary hip arthroplasty reduces hospital and postacute care utilization while maintaining or improving care quality. J Clin Anesth. 2021;68:110072. - PubMed
-
- Dermawan J.K., Goldblum A., Reith J.D., Kilpatrick S.E. Accurate and reliable diagnosis of avascular necrosis of the femoral head from total hip arthroplasty specimens requires pathologic examination. Am J Clin Pathol. 2021;155:565–574. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials